PUBLISHER: Acute Market Reports | PRODUCT CODE: 1510303
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1510303
Anthelmintic Drugs Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The anthelmintic drugs market comprises the development, production, and distribution of pharmaceuticals used to treat and prevent helminthic infections, which are caused by parasitic worms such as roundworms, tapeworms, and flukes. These drugs are crucial in both human and veterinary medicine, helping to control infections that can lead to significant health issues ranging from malnutrition and anemia to severe organ damage. Anthelmintic drugs function by targeting the biological processes of worms, leading to their death or expulsion from the host body. The necessity for these medications is particularly high in tropical and subtropical regions where helminth infections are prevalent due to factors like warm climate and inadequate sanitation. These conditions facilitate the life cycles of various parasitic worms, increasing infection rates among human and animal populations. As of 2023, the global anthelmintic drugs market is growing at a steady pace with a Compound Annual Growth Rate (CAGR) of 3.7%. This growth is driven by several factors, including increasing awareness of parasitic infections, government initiatives to control these infections, and ongoing improvements in diagnostic technologies which help in identifying infections more accurately and promptly. Additionally, the expansion of veterinary healthcare and the rising pet ownership in emerging economies contribute to the market's growth by increasing the demand for animal-targeted anthelmintic treatments. The market's expansion is also bolstered by the development of new and more effective anthelmintic compounds that address drug resistance, a growing challenge in this field.]
Global Increase in Parasitic Infections
A primary driver of the anthelmintic drugs market is the global rise in parasitic infections, particularly in regions with limited access to clean water and adequate sanitation. Parasitic worms such as hookworms, roundworms, and tapeworms pose significant health risks, including malnutrition, anemia, and impaired cognitive development, especially in children in developing countries. These health concerns drive the demand for effective anthelmintic treatments. The prevalence of these infections is particularly high in sub-Saharan Africa, South Asia, and Latin America, where ongoing public health initiatives aim to reduce the incidence of parasitic infections through mass drug administration programs. The increasing awareness and governmental focus on controlling parasitic infections enhance the demand for anthelmintic drugs, supporting market growth.
Expansion into Veterinary Healthcare
The anthelmintic drugs market sees significant opportunities in the expansion into veterinary healthcare. With the global rise in pet ownership and the expansion of livestock production to meet the increasing demand for animal protein, there is a growing need for effective animal healthcare solutions, including anthelmintic treatments. Animals, just like humans, are prone to parasitic infections that can affect their health and productivity, impacting economic outcomes in agricultural industries. The development and approval of new anthelmintic drugs for animals not only improve animal welfare but also ensure food safety and public health by controlling zoonotic diseases.
High Cost of Drug Development
One major restraint impacting the anthelmintic drugs market is the high cost associated with the research and development of new drugs. Developing novel anthelmintic treatments involves significant investment in terms of time and resources, often taking several years to move from discovery through clinical trials to market. Additionally, the return on investment can be uncertain, especially when targeting diseases that are predominantly found in poorer regions of the world where patients and healthcare systems may have limited ability to pay for new treatments. This financial risk can deter pharmaceutical companies from investing in the development of new anthelmintic drugs, thereby slowing the introduction of innovative therapies that could address emerging drug resistances.
Challenge of Drug Resistance
A critical challenge facing the anthelmintic drugs market is the issue of drug resistance. As with antibiotics, frequent and widespread use of anthelmintics has led to the development of resistance among certain species of parasitic worms. This resistance threatens to undermine the efficacy of existing drugs, making it increasingly difficult to control parasitic infections effectively. The challenge is compounded by the slow pace of new drug development and the limited economic incentives for pharmaceutical companies to invest in novel anthelmintics. Addressing this issue requires not only the development of new drugs but also improved strategies for drug administration and use to prolong the efficacy of existing treatments and mitigate the spread of resistance.
Market Segmentation by Drug Class
In the anthelmintic drugs market, segmentation by drug class includes Benzimidazole, Piperazine, and Others. Currently, Benzimidazole derivatives generate the highest revenue due to their broad-spectrum efficacy against a range of helminth infections and their established position in both human and veterinary medicine. However, the Others category, which includes newer and more specialized drugs, is projected to experience the highest CAGR. This growth is driven by the ongoing development and approval of new anthelmintic compounds designed to overcome resistance issues inherent in older drug classes.
Market Segmentation by Route of Administration
Concerning the route of administration, the market is segmented into oral and injectable forms. Oral medications hold the largest revenue share due to their ease of administration, safety profile, and suitability for mass drug administration campaigns in endemic regions. Conversely, injectable anthelmintics are expected to register the highest CAGR, reflecting their increasing use in veterinary practices where precise dosing and immediate effectiveness are critical, especially in acute infection scenarios.
Market Segmentation by Application
The market segmentation by application divides into human and animal sectors. The human segment accounts for the majority of the market's revenue, supported by large-scale public health programs targeting helminth infections globally. The animal segment, however, is anticipated to grow at the highest CAGR, spurred by the expanding livestock industries and rising pet ownership, which necessitate regular deworming to maintain animal health and productivity.
Market Segmentation by Target Pathogen
In terms of target pathogens, the market includes Ascaris lumbricoides (Roundworm), Trichuris trichiura (Whipworm), Enterobius vermicularis (Pinworm), Ancylostoma duodenale (Hookworm), and Others. The segment targeting Ancylostoma duodenale generates the highest revenue, given the high prevalence of hookworm infections worldwide and the significant health impact they have, particularly in developing countries. However, the segment for Other pathogens, which includes emerging and less common parasites, is expected to see the highest CAGR as new research focuses on addressing a broader spectrum of infections with novel treatment options.
Market Segmentation by Distribution Channel
Finally, regarding the distribution channel, the segments include hospital pharmacies, retail pharmacies, online pharmacies, veterinary pharmacies, and veterinary hospitals & clinics. Hospital pharmacies currently lead in revenue due to their pivotal role in dispensing medications during hospital treatments and public health initiatives. However, online pharmacies are expected to grow at the fastest rate due to the increasing consumer preference for the convenience and often lower costs associated with online purchasing, alongside wider availability and accessibility of pharmaceutical products through e-commerce platforms.
Regional Insights
In the geographic analysis of the anthelmintic drugs market, Africa and Southeast Asia were regions that accounted for the highest revenue share in 2023 due to their high prevalence of parasitic infections, driven by climatic conditions favorable to parasites and challenges in sanitation and healthcare access. However, Asia-Pacific is expected to display the highest CAGR from 2024 to 2032. This projected growth can be attributed to improving healthcare infrastructure, increasing government initiatives to control parasitic diseases, and rising awareness about the importance of deworming in both humans and animals. These factors, coupled with the growing livestock sector in countries like China and India, are expected to drive demand for anthelmintic drugs in the region.
Competitive Trends
Regarding competitive trends, key players in the anthelmintic drugs market include Novartis AG, Zoetis, Inc., Amneal Pharmaceuticals, Inc., Cipla Inc., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Bayer AG, Merck & Co. Inc. (Intervet Inc.), and Boehringer Ingelheim International GmbH. In 2023, these companies concentrated on expanding their market reach through strategic alliances, mergers, and acquisitions, as well as focusing on research and development to innovate new drug formulations to combat resistance issues. From 2024 to 2032, these players are expected to continue their focus on innovation but also enhance their engagement in emerging markets. Key strategies will likely include forming partnerships with local companies to facilitate market entry, improving distribution channels, and investing in local manufacturing facilities to reduce costs and improve accessibility to their products. These strategic moves are anticipated to help these companies capitalize on new growth opportunities while addressing the complex challenges posed by evolving global health and regulatory landscapes.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Anthelmintic Drugs market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Anthelmintic Drugs market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Drug Class
- Benzimidazole
- Piperazine
- Others
Route of Administration
- Oral
- Injectable
Application
- Human
Parenchymal Neurocysticercosis
Gastrointestinal Infections
- Animal
Target Pathogen
- Ascaris Lumbricoides (Roundworm)
- Trichuris Trichiura (Whipworm)
- Enterobius Vermicularis (Pinworm)
- Ancylostoma Duodenale (Hookworm)
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Veterinary Pharmacies
- Veterinary Hospitals & Clinics
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Anthelmintic Drugs market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Anthelmintic Drugs market?
Which is the largest regional market for Anthelmintic Drugs market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Anthelmintic Drugs market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Anthelmintic Drugs market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Anthelmintic Drugs Market
- 2.2. Global Anthelmintic Drugs Market, By Drug Class, 2023 (US$ Million)
- 2.3. Global Anthelmintic Drugs Market, By Route of Administration, 2023 (US$ Million)
- 2.4. Global Anthelmintic Drugs Market, By Application, 2023 (US$ Million)
- 2.5. Global Anthelmintic Drugs Market, By Target Pathogen, 2023 (US$ Million)
- 2.6. Global Anthelmintic Drugs Market, By Distribution Channel, 2023 (US$ Million)
- 2.7. Global Anthelmintic Drugs Market, By Geography, 2023 (US$ Million)
- 2.8. Attractive Investment Proposition by Geography, 2023
3. Anthelmintic Drugs Market: Competitive Analysis
- 3.1. Market Positioning of Key Anthelmintic Drugs Market Vendors
- 3.2. Strategies Adopted by Anthelmintic Drugs Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Anthelmintic Drugs Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Anthelmintic Drugs Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Benzimidazole
- 5.3.2. Piperazine
- 5.3.3. Others
6. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Oral
- 6.3.2. Injectable
7. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2023 Versus 2032
- 7.3. Market Segmentation
- 7.3.1. Human
- 7.3.1.1. Parenchymal Neurocysticercosis
- 7.3.1.2. Gastrointestinal Infections
- 7.3.2. Animal
- 7.3.1. Human
8. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Growth & Revenue Analysis: 2023 Versus 2032
- 8.3. Market Segmentation
- 8.3.1. Ascaris Lumbricoides (Roundworm)
- 8.3.2. Trichuris Trichiura (Whipworm)
- 8.3.3. Enterobius Vermicularis (Pinworm)
- 8.3.4. Ancylostoma Duodenale (Hookworm)
- 8.3.5. Others
9. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Growth & Revenue Analysis: 2023 Versus 2032
- 9.3. Market Segmentation
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Online Pharmacies
- 9.3.4. Veterinary Pharmacies
- 9.3.5. Veterinary Hospitals & Clinics
10. North America Anthelmintic Drugs Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 10.3. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 10.4. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 10.6. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.7.Anthelmintic Drugs Market: By Region, 2022-2032, USD (Million)
- 10.7.1.North America
- 10.7.1.1. U.S.
- 10.7.1.1.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 10.7.1.1.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 10.7.1.1.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 10.7.1.1.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 10.7.1.1.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.7.1.2. Canada
- 10.7.1.2.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 10.7.1.2.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 10.7.1.2.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 10.7.1.2.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 10.7.1.2.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.7.1.3. Rest of North America
- 10.7.1.3.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 10.7.1.3.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 10.7.1.3.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 10.7.1.3.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 10.7.1.3.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 10.7.1.1. U.S.
- 10.7.1.North America
11. UK and European Union Anthelmintic Drugs Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.3. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.4. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.6. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.Anthelmintic Drugs Market: By Region, 2022-2032, USD (Million)
- 11.7.1.UK and European Union
- 11.7.1.1. UK
- 11.7.1.1.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.1.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.1.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.1.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.1.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.2. Germany
- 11.7.1.2.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.2.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.2.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.2.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.2.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.3. Spain
- 11.7.1.3.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.3.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.3.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.3.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.3.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.4. Italy
- 11.7.1.4.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.4.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.4.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.4.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.4.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.5. France
- 11.7.1.5.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.5.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.5.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.5.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.5.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.6. Rest of Europe
- 11.7.1.6.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 11.7.1.6.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 11.7.1.6.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 11.7.1.6.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 11.7.1.6.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 11.7.1.1. UK
- 11.7.1.UK and European Union
12. Asia Pacific Anthelmintic Drugs Market, 2022-2032, USD (Million)
- 12.1. Market Overview
- 12.2. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.3. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.4. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.6. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.Anthelmintic Drugs Market: By Region, 2022-2032, USD (Million)
- 12.7.1.Asia Pacific
- 12.7.1.1. China
- 12.7.1.1.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.1.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.1.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.1.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.1.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.2. Japan
- 12.7.1.2.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.2.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.2.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.2.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.2.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.3. India
- 12.7.1.3.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.3.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.3.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.3.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.3.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.4. Australia
- 12.7.1.4.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.4.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.4.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.4.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.4.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.5. South Korea
- 12.7.1.5.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.5.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.5.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.5.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.5.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.6. Rest of Asia Pacific
- 12.7.1.6.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 12.7.1.6.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 12.7.1.6.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 12.7.1.6.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 12.7.1.6.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 12.7.1.1. China
- 12.7.1.Asia Pacific
13. Latin America Anthelmintic Drugs Market, 2022-2032, USD (Million)
- 13.1. Market Overview
- 13.2. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 13.3. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 13.4. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 13.5. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 13.6. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 13.7.Anthelmintic Drugs Market: By Region, 2022-2032, USD (Million)
- 13.7.1.Latin America
- 13.7.1.1. Brazil
- 13.7.1.1.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 13.7.1.1.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 13.7.1.1.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 13.7.1.1.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 13.7.1.1.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 13.7.1.2. Mexico
- 13.7.1.2.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 13.7.1.2.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 13.7.1.2.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 13.7.1.2.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 13.7.1.2.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 13.7.1.3. Rest of Latin America
- 13.7.1.3.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 13.7.1.3.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 13.7.1.3.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 13.7.1.3.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 13.7.1.3.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 13.7.1.1. Brazil
- 13.7.1.Latin America
14. Middle East and Africa Anthelmintic Drugs Market, 2022-2032, USD (Million)
- 14.1. Market Overview
- 14.2. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 14.3. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 14.4. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 14.5. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 14.6. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 14.7.Anthelmintic Drugs Market: By Region, 2022-2032, USD (Million)
- 14.7.1.Middle East and Africa
- 14.7.1.1. GCC
- 14.7.1.1.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 14.7.1.1.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 14.7.1.1.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 14.7.1.1.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 14.7.1.1.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 14.7.1.2. Africa
- 14.7.1.2.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 14.7.1.2.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 14.7.1.2.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 14.7.1.2.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 14.7.1.2.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 14.7.1.3. Rest of Middle East and Africa
- 14.7.1.3.1. Anthelmintic Drugs Market: By Drug Class, 2022-2032, USD (Million)
- 14.7.1.3.2. Anthelmintic Drugs Market: By Route of Administration, 2022-2032, USD (Million)
- 14.7.1.3.3. Anthelmintic Drugs Market: By Application, 2022-2032, USD (Million)
- 14.7.1.3.4. Anthelmintic Drugs Market: By Target Pathogen, 2022-2032, USD (Million)
- 14.7.1.3.5. Anthelmintic Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
- 14.7.1.1. GCC
- 14.7.1.Middle East and Africa
15. Company Profile
- 15.1. Novartis AG
- 15.1.1. Company Overview
- 15.1.2. Financial Performance
- 15.1.3. Product Portfolio
- 15.1.4. Strategic Initiatives
- 15.2. Zoetis, Inc.
- 15.2.1. Company Overview
- 15.2.2. Financial Performance
- 15.2.3. Product Portfolio
- 15.2.4. Strategic Initiatives
- 15.3. Amneal Pharmaceuticals, Inc.
- 15.3.1. Company Overview
- 15.3.2. Financial Performance
- 15.3.3. Product Portfolio
- 15.3.4. Strategic Initiatives
- 15.4. Cipla Inc.
- 15.4.1. Company Overview
- 15.4.2. Financial Performance
- 15.4.3. Product Portfolio
- 15.4.4. Strategic Initiatives
- 15.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
- 15.5.1. Company Overview
- 15.5.2. Financial Performance
- 15.5.3. Product Portfolio
- 15.5.4. Strategic Initiatives
- 15.6. Sun Pharmaceutical Industries Ltd.
- 15.6.1. Company Overview
- 15.6.2. Financial Performance
- 15.6.3. Product Portfolio
- 15.6.4. Strategic Initiatives
- 15.7. GlaxoSmithKline plc
- 15.7.1. Company Overview
- 15.7.2. Financial Performance
- 15.7.3. Product Portfolio
- 15.7.4. Strategic Initiatives
- 15.8. Bayer AG
- 15.8.1. Company Overview
- 15.8.2. Financial Performance
- 15.8.3. Product Portfolio
- 15.8.4. Strategic Initiatives
- 15.9. Merck & Co. Inc. (Intervet Inc.)
- 15.9.1. Company Overview
- 15.9.2. Financial Performance
- 15.9.3. Product Portfolio
- 15.9.4. Strategic Initiatives
- 15.10. Boehringer Ingelheim International GmbH
- 15.10.1. Company Overview
- 15.10.2. Financial Performance
- 15.10.3. Product Portfolio
- 15.10.4. Strategic Initiatives
- 15.11. Other Notable Players
- 15.11.1. Company Overview
- 15.11.2. Financial Performance
- 15.11.3. Product Portfolio
- 15.11.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 2 Global Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 3 Global Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 4 Global Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 5 Global Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 6 Global Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 7 North America Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 8 North America Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 9 North America Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 10 North America Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 11 North America Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 12 North America Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 13 U.S. Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 14 U.S. Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 15 U.S. Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 16 U.S. Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 17 U.S. Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 18 U.S. Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 19 Canada Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 20 Canada Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 21 Canada Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 22 Canada Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 23 Canada Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 24 Canada Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 25 Rest of North America Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 26 Rest of North America Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 27 Rest of North America Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 28 Rest of North America Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 29 Rest of North America Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 30 Rest of North America Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 31 UK and European Union Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 32 UK and European Union Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 33 UK and European Union Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 34 UK and European Union Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 35 UK and European Union Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 36 UK and European Union Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 37 UK Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 38 UK Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 39 UK Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 40 UK Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 41 UK Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 42 UK Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 43 Germany Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 44 Germany Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 45 Germany Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 46 Germany Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 47 Germany Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 48 Germany Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 49 Spain Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 50 Spain Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 51 Spain Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 52 Spain Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 53 Spain Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 54 Spain Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 55 Italy Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 56 Italy Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 57 Italy Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 58 Italy Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 59 Italy Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 60 Italy Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 61 France Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 62 France Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 63 France Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 64 France Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 65 France Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 66 France Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 67 Rest of Europe Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 68 Rest of Europe Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 69 Rest of Europe Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 70 Rest of Europe Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 71 Rest of Europe Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 72 Rest of Europe Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 73 Asia Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 74 Asia Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 75 Asia Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 76 Asia Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 77 Asia Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 78 Asia Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 79 China Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 80 China Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 81 China Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 82 China Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 83 China Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 84 China Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 85 Japan Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 86 Japan Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 87 Japan Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 88 Japan Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 89 Japan Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 90 Japan Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 91 India Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 92 India Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 93 India Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 94 India Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 95 India Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 96 India Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 97 Australia Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 98 Australia Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 99 Australia Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 100 Australia Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 101 Australia Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 102 Australia Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 103 South Korea Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 104 South Korea Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 105 South Korea Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 106 South Korea Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 107 South Korea Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 108 South Korea Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 109 Latin America Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 110 Latin America Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 111 Latin America Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 112 Latin America Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 113 Latin America Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 114 Latin America Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 115 Brazil Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 116 Brazil Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 117 Brazil Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 118 Brazil Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 119 Brazil Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 120 Brazil Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 121 Mexico Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 122 Mexico Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 123 Mexico Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 124 Mexico Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 125 Mexico Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 126 Mexico Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 127 Rest of Latin America Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 128 Rest of Latin America Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 129 Rest of Latin America Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 130 Rest of Latin America Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 131 Rest of Latin America Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 132 Rest of Latin America Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 133 Middle East and Africa Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 134 Middle East and Africa Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 135 Middle East and Africa Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 136 Middle East and Africa Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 137 Middle East and Africa Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 138 Middle East and Africa Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 139 GCC Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 140 GCC Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 141 GCC Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 142 GCC Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 143 GCC Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 144 GCC Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 145 Africa Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 146 Africa Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 147 Africa Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 148 Africa Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 149 Africa Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 150 Africa Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
- TABLE 151 Rest of Middle East and Africa Anthelmintic Drugs Market By Drug Class, 2022-2032, USD (Million)
- TABLE 152 Rest of Middle East and Africa Anthelmintic Drugs Market By Route of Administration, 2022-2032, USD (Million)
- TABLE 153 Rest of Middle East and Africa Anthelmintic Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 154 Rest of Middle East and Africa Anthelmintic Drugs Market By Human, 2022-2032, USD (Million)
TABLE 155 Rest of Middle East and Africa Anthelmintic Drugs Market By Target Pathogen, 2022-2032, USD (Million)
- TABLE 156 Rest of Middle East and Africa Anthelmintic Drugs Market By Distribution Channel, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Anthelmintic Drugs Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Anthelmintic Drugs Market: Quality Assurance
- FIG. 5 Global Anthelmintic Drugs Market, By Drug Class, 2023
- FIG. 6 Global Anthelmintic Drugs Market, By Route of Administration, 2023
- FIG. 7 Global Anthelmintic Drugs Market, By Application, 2023
- FIG. 8 Global Anthelmintic Drugs Market, By Target Pathogen, 2023
- FIG. 9 Global Anthelmintic Drugs Market, By Distribution Channel, 2023
- FIG. 10 Global Anthelmintic Drugs Market, By Geography, 2023
- FIG. 11 Market Geographical Opportunity Matrix - Global Anthelmintic Drugs Market, 2023
FIG. 12Market Positioning of Key Anthelmintic Drugs Market Players, 2023
FIG. 13Global Anthelmintic Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 14 Global Anthelmintic Drugs Market, By Drug Class, 2023 Vs 2032, %
- FIG. 15 Global Anthelmintic Drugs Market, By Route of Administration, 2023 Vs 2032, %
- FIG. 16 Global Anthelmintic Drugs Market, By Application, 2023 Vs 2032, %
- FIG. 17 Global Anthelmintic Drugs Market, By Target Pathogen, 2023 Vs 2032, %
- FIG. 18 Global Anthelmintic Drugs Market, By Distribution Channel, 2023 Vs 2032, %
- FIG. 19 U.S. Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 20 Canada Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 21 Rest of North America Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 22 UK Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 23 Germany Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 24 Spain Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 25 Italy Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 26 France Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 27 Rest of Europe Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 28 China Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 29 Japan Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 30 India Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 31 Australia Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 32 South Korea Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 33 Rest of Asia Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 34 Brazil Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 35 Mexico Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 36 Rest of Latin America Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 37 GCC Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 38 Africa Anthelmintic Drugs Market (US$ Million), 2022 - 2032
- FIG. 39 Rest of Middle East and Africa Anthelmintic Drugs Market (US$ Million), 2022 - 2032
